Correlation Between Vaccinex and Magenta Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Magenta Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Magenta Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Magenta Therapeutics, you can compare the effects of market volatilities on Vaccinex and Magenta Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Magenta Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Magenta Therapeutics.
Diversification Opportunities for Vaccinex and Magenta Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Vaccinex and Magenta is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Magenta Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Magenta Therapeutics and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Magenta Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Magenta Therapeutics has no effect on the direction of Vaccinex i.e., Vaccinex and Magenta Therapeutics go up and down completely randomly.
Pair Corralation between Vaccinex and Magenta Therapeutics
If you would invest 82.00 in Magenta Therapeutics on September 2, 2024 and sell it today you would earn a total of 0.00 from holding Magenta Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Vaccinex vs. Magenta Therapeutics
Performance |
Timeline |
Vaccinex |
Magenta Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Vaccinex and Magenta Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vaccinex and Magenta Therapeutics
The main advantage of trading using opposite Vaccinex and Magenta Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Magenta Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Magenta Therapeutics will offset losses from the drop in Magenta Therapeutics' long position.Vaccinex vs. Tff Pharmaceuticals | Vaccinex vs. Eliem Therapeutics | Vaccinex vs. Inhibrx | Vaccinex vs. Enliven Therapeutics |
Magenta Therapeutics vs. Assembly Biosciences | Magenta Therapeutics vs. Instil Bio | Magenta Therapeutics vs. Nuvation Bio | Magenta Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |